Dr. Constantine Karakousis: The Quintessential Surgical Oncologist Nicholas J. PetrelliCharles Balch Sarcoma 08 October 2022 Pages: 7939 - 7941
Moving Forward with Omission of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy Henry M. Kuerer ASO Perspectives 24 August 2022 Pages: 7942 - 7944
Recognizing Disparities in Breast Cancer Patient-Reported Outcome Measures Olga KantorLaura Dominici Breast Oncology 27 September 2022 Pages: 7945 - 7946
Supply and Demand: Is the Surgical Oncology Match in a Bear Market? Dan G. Blazer III Global Health Services Research 14 September 2022 Pages: 7947 - 7949
Decreasing Medicare Reimbursements for Surgical Oncology Procedures: Future Implications Mashaal DhirThomas J. VanderMeer Global Health Services Research 05 October 2022 Pages: 7950 - 7952
Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome Martha E. TekeLauren A. GambleJeremy L. Davis ASO Research Letter 26 July 2022 Pages: 7955 - 7957
Transgender and Non-binary Persons in Contemporary Oncology Randomized Clinical Trials Enrique O. MartinezMicah RubinChandler S. Cortina ASO Research Letter 23 August 2022 Pages: 7958 - 7960
A Phase III, Randomized, Controlled Trial Comparing Open Versus Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma Martha E. TekeAreeba SaifJohn J. Doski ASO Research Letter 09 September 2022 Pages: 7961 - 7963
Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, or Disease Stage? Marissa K. SrourAudree B. TadrosMonica Morrow Breast Oncology 23 September 2022 Pages: 7964 - 7973
ASO Author Reflections: Engagement in Patient-Reported Outcomes for Breast Cancer Marissa K. SrourAudree B. TadrosMonica Morrow ASO Author Reflections 04 September 2022 Pages: 7974 - 7974
ASO Visual Abstract: Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, and Disease Stage? Marissa K. SrourAudree B. TadrosMonica Morrow ASO Visual Abstract 13 September 2022 Pages: 7975 - 7976
Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups Nishwant SwamiTiffany NguyenFumiko Chino Breast Oncology 11 August 2022 Pages: 7977 - 7987
ASO Author Reflections: The Need for Disaggregated Study among Hispanic Populations Nishwant SwamiEdward Christopher DeeFumiko Chino ASO Author Reflections 01 August 2022 Pages: 7988 - 7989
ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups Nishwant SwamiTiffany NguyenFumiko Chino ASO Visual Abstract 06 August 2022 Pages: 7990 - 7991
Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery—A Rare Complication and a Proposed Management Strategy from the British and Italian Experience Arwa AshoorGermana LissidiniMelissa Ley-Hui Tan Breast Oncology 18 July 2022 Pages: 7992 - 7999
ASO Author Reflections: Chyle Leak after Axillary Node Clearance in Breast Cancer Surgery, a Successful Management Approach from Leading Centres Arwa AshoorGermana LissidiniMelissa Ley-Hui Tan ASO Author Reflections 09 July 2022 Pages: 8000 - 8000
ASO Visual Abstract: Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery: A Rare Complication and a Proposed Management Strategy from the British and Italian Experience Arwa AshoorGermana LissidiniMelissa Ley-Hui Tan ASO Visual Abstract 04 September 2022 Pages: 8001 - 8001
Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals? Austin D. WilliamsChau T. DangAndrea V. Barrio Breast Oncology 24 July 2022 Pages: 8002 - 8011
ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer Austin D. WilliamsAndrea V. Barrio ASO Author Reflections 08 August 2022 Pages: 8012 - 8013
ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly—Are We Accomplishing Our Treatment Goals? Austin D. WilliamsChau T. DangAndrea V. Barrio ASO Visual Abstract 28 July 2022 Pages: 8014 - 8015
Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx Olga KantorHarold J. BursteinElizabeth A. Mittendorf Breast Oncology 27 July 2022 Pages: 8016 - 8023
ASO Visual Abstract: Expanding Staging Criteria in T1–2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx Olga KantorHarold J. BursteinElizabeth A. Mittendorf ASO Visual Abstract 28 July 2022 Pages: 8024 - 8025
Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis Yingbo ShaoYang YuHui Liu Breast Oncology 06 August 2022 Pages: 8026 - 8034
ASO Visual Abstract: Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting—A Retrospective Analysis Yingbo ShaoYang YuHui Liu ASO Visual Abstract 16 August 2022 Pages: 8035 - 8036
Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy Austin D. WilliamsAtif J. KhanAnita Mamtani Breast Oncology 11 August 2022 Pages: 8037 - 8043
ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy Austin D. WilliamsAnita Mamtani ASO Author Reflections 16 August 2022 Pages: 8044 - 8045
ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy Austin D. WilliamsAtif J. KhanAnita Mamtani ASO Visual Abstract 17 August 2022 Pages: 8046 - 8047
Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ Megan E. TeschShoshana M. RosenbergAnn H. Partridge Breast Oncology 12 August 2022 Pages: 8048 - 8057
ASO Visual Abstract: Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ Megan E. TeschShoshana M. RosenbergAnn H. Partridge ASO Visual Abstract 29 August 2022 Pages: 8058 - 8059
Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy Erin A. ElderChad A. LivasyRichard L. White Jr. Breast Oncology 18 August 2022 Pages: 8060 - 8069
ASO Author Reflections: Residual Cancer Burden Across Phenotypic Subtypes E. Alexa ElderRichard White ASO Author Reflections 04 August 2022 Pages: 8070 - 8070
ASO Visual Abstract: Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy Erin A. ElderChad A. LivasyRichard L. White Jr ASO Visual Abstract 04 September 2022 Pages: 8071 - 8071
Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer Ananya Gopika NairVasily GiannakeasDavid W. Lim Breast Oncology 08 September 2022 Pages: 8072 - 8082
ASO Visual Abstract: Contemporary Trends in Breast Reconstruction Use and Impact on Survival Amongst Women with Inflammatory Breast Cancer Ananya Gopika NairVasily GiannakeasDavid W. Lim ASO Visual Abstract 07 September 2022 Pages: 8083 - 8083
Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer Giovanni CorsoFrancesca MagnoniPaolo Veronesi Breast Oncology 15 September 2022 Pages: 8084 - 8089
ASO Author Reflections: Is Breast-Conserving Surgery a Safe Treatment Option for High-Risk Breast Cancer? Francesca MagnoniGiovanni Corso ASO Author Reflections 20 September 2022 Pages: 8090 - 8091
Breast Cancer Screening in Young Women with the Advent of Newer Techniques: Current Evidence and Future Considerations Debdeep SahaAkshay BalasubramanianSudharsanan Sundaramurthi Breast Oncology 08 October 2022 Pages: 8092 - 8093
Application and Match Rates in the Complex General Surgical Oncology Match Jason SilvestreJessica R. SmithRachel R. Kelz Global Health Services Research 23 August 2022 Pages: 8094 - 8098
Trends in Reimbursement for Index Surgical Oncology Procedures in Contemporary Practice: Declining Reimbursement for Surgical Oncology Procedures—How Low Do We Go? Thomas C. HydrickJack HaglinNabil Wasif Global Health Services Research 29 September 2022 Pages: 8099 - 8106
Gender Disparities in Presentations at the Society of Surgical Oncology (SSO) Meetings From 2014 to 2019 Heather G. LyuPamela LuNancy L. Cho Global Health Services Research 12 July 2022 Pages: 8107 - 8114
ASO Visual Abstract: Gender Disparities in Presentations at the Society of Surgical Oncology (SSO) Meetings from 2014 to 2019 Heather G. LyuPamela LuNancy L. Cho ASO Visual Abstract 28 July 2022 Pages: 8115 - 8116
Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models Chenyi XieYihuai HuHong Yang Thoracic Oncology 26 August 2022 Pages: 8117 - 8126
ASO Author Reflections: Radiomics-Based Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Chenyi XieYihuai HuHong Yang ASO Author Reflections 06 August 2022 Pages: 8127 - 8128
ASO Visual Abstract: Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine CT Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models Chenyi XieYihuai HuHong Yang ASO Visual Abstract 06 September 2022 Pages: 8129 - 8130
Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer Tsuyoshi HaradaTetsuya TsujiTakeo Fujita Thoracic Oncology 17 August 2022 Pages: 8131 - 8139
ASO Author Reflections: Significance of Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy in Older Patients with Esophageal Cancer Tsuyoshi HaradaTetsuya TsujiTakeo Fujita ASO Author Reflections 17 August 2022 Pages: 8140 - 8141
ASO Visual Abstract: Prognostic Impact of the Loss of Skeletal Muscle Mass during Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer Tsuyoshi HaradaTetsuya TsujiTakeo Fujita ASO Visual Abstract 10 September 2022 Pages: 8142 - 8143
A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients Zihuai WangZhenyu YangLunxu Liu Thoracic Oncology 18 August 2022 Pages: 8144 - 8153
ASO Author Reflections: Comprehensive Comparison of N Staging Subclassification Methods for Non-Small-Cell Lung Cancer Zhenyu YangZihuai WangLunxu Liu ASO Author Reflections 21 August 2022 Pages: 8154 - 8155